BOEHRINGER INGELHEIM
About
Support the early Oncology clinical drug research and development process by providing strategic planning and execution, including clinical trial design and all aspects of descriptive, diagnostic, predictive and prescriptive analytics of data related to clinical projects like actual trial data, registries and real-world data bases. Represent biostatistics and coordinate the inputs from programing and data management at a substance/asset level regarding data science related aspects. Collaborat...
Updates & Highlights
Boehringer Ingelheim to scrap €900 mln investment in Germany, Handelsblatt reports
Boehringer Ingelheim to scrap €900 mln investment in Germany, Handelsblatt reports
TradingView · 3 days ago
Boehringer Ingelheim joins AgResults and GALVmed in the FMD Vaccine Challenge Project.
Boehringer Ingelheim joins AgResults and GALVmed in the FMD Vaccine Challenge Project.
Farmers Review Africa · 4 days ago
Boehringer Ingelheim enters the search for Foot and Mouth Disease Vaccine in Eastern Africa
Boehringer Ingelheim enters the search for Foot and Mouth Disease Vaccine in Eastern Africa
The Tanzania Times · 4 days ago
Recent Openings
View all 7 jobsSenior Data Scientist
Biberach an der Riß, BW, DE
(Senior) Data Scientist
Biberach an der Riß, BW, DE
Quality Medicine Data Scientist (m/f/d)
Wien, W, AT
(Senior) Principal Clinical Data Scientist
Biberach an der Riß, BW, DE
All Jobs
Senior Data Scientist
Biberach an der Riß, BW, DE
(Senior) Data Scientist
Biberach an der Riß, BW, DE
Quality Medicine Data Scientist (m/f/d)
Wien, W, AT
(Senior) Principal Clinical Data Scientist
Biberach an der Riß, BW, DE
Senior/Principal Clinical Data Scientist HTA
Biberach an der Riß, BW, DE
SR AD/ AD, Principal Clinical Data Scientist -Early Oncology Drug Development (Remote)
Ridgefield, CT, US
SR AD/ AD, Principal Clinical Data Scientist -Early Oncology Drug Development
Ridgefield, CT, US
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Boehringer Ingelheim?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentBoehringer Ingelheim to scrap €900 mln investment in Germany, Handelsblatt reports
Boehringer Ingelheim to scrap €900 mln investment in Germany, Handelsblatt reports
TradingView · 3 days ago
Boehringer Ingelheim joins AgResults and GALVmed in the FMD Vaccine Challenge Project.
Boehringer Ingelheim joins AgResults and GALVmed in the FMD Vaccine Challenge Project.
Farmers Review Africa · 4 days ago
Boehringer Ingelheim enters the search for Foot and Mouth Disease Vaccine in Eastern Africa
Boehringer Ingelheim enters the search for Foot and Mouth Disease Vaccine in Eastern Africa
The Tanzania Times · 4 days ago
Boehringer Ingelheim adds ex-Teva executive to patent team
Boehringer Ingelheim adds ex-Teva executive to patent team
Life Sciences Intellectual Property Review · 10 days ago
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
Toronto Star · 15 days ago
Boehringer Ingelheim Expands NIPER Partnerships
Boehringer Ingelheim Expands NIPER Partnerships
Machine Maker · 16 days ago
Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
PR Newswire · 16 days ago
Boehringer Ingelheim Says JASCAYD Approved In Japan, Advancing Global Access To New IPF & PPF Treatment
Boehringer Ingelheim Says JASCAYD Approved In Japan, Advancing Global Access To New IPF & PPF Treatment
TradingView · 19 days ago
Boehringer Ingelheim India, NIPER Collab to Expand Research Across Pharma Hubs
Boehringer Ingelheim India, NIPER Collab to Expand Research Across Pharma Hubs
Deccan Chronicle · 21 days ago
Boehringer Ingelheim Secures Next-Generation Autoimmune Therapy Candidate
Boehringer Ingelheim Secures Next-Generation Autoimmune Therapy Candidate
thelec.net · 23 days ago
Brainomix and Boehringer Ingelheim continue partnership in pulmonary fibrosis
Brainomix and Boehringer Ingelheim continue partnership in pulmonary fibrosis
Manufacturing Chemist · 24 days ago
Boehringer Ingelheim licenses Immunitas antibody program
Boehringer Ingelheim licenses Immunitas antibody program
BioWorld News · 24 days ago
Boehringer Ingelheim deepens AI imaging pact with Brainomix in new fibrosis study
Boehringer Ingelheim deepens AI imaging pact with Brainomix in new fibrosis study
FirstWord Pharma · 24 days ago
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
Pharmaceutical Executive · 24 days ago
Boehringer Ingelheim Advances Partnership with Brainomix to Improve Pulmonary Fibrosis Care
Boehringer Ingelheim Advances Partnership with Brainomix to Improve Pulmonary Fibrosis Care
Contract Pharma · 25 days ago
Brainomix, Boehringer Ingelheim Advance Partnership in Pulmonary Fibrosis
Brainomix, Boehringer Ingelheim Advance Partnership in Pulmonary Fibrosis
Medical Product Outsourcing · 25 days ago
Brainomix and Boehringer Ingelheim advance strategic partnership in pulmonary fibrosis
Brainomix and Boehringer Ingelheim advance strategic partnership in pulmonary fibrosis
PharmaLive · 25 days ago
Boehringer Ingelheim licenses preclinical antibody program
Boehringer Ingelheim licenses preclinical antibody program
GlobeNewswire · 25 days ago
Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
PR Newswire · 25 days ago
The Escalator: Johnson & Johnson, Fingerpaint Group, Boehringer Ingelheim and more
The Escalator: Johnson & Johnson, Fingerpaint Group, Boehringer Ingelheim and more
Medical Marketing and Media · 30 days ago